Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shreyas Nellamkuziyil Michael

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Pan African Medical Journal|July 31, 2023
Giant right hydronephrosis with underlying double malignancy: a case reportShreyas Nellamkuziyil Michael, Pirzada Faisal Masood, Umesh Sharma, et al.
Urologia|November 11, 2025
A randomized study comparing outcomes of intravesical Gemcitabine, Mitomycin C (as hyperthermic intravesical chemotherapy-HIVEC) and Bacillus-Calmette Guerin in intermediate and high-risk non-muscle invasive bladder cancerShreyas Nellamkuziyil Michael, Arun Makkar, Supreeth Nagaraju, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Pan African Medical Journal|July 31, 2023
Giant right hydronephrosis with underlying double malignancy: a case reportShreyas Nellamkuziyil Michael, Pirzada Faisal Masood, Umesh Sharma, et al.
Urologia|November 11, 2025
A randomized study comparing outcomes of intravesical Gemcitabine, Mitomycin C (as hyperthermic intravesical chemotherapy-HIVEC) and Bacillus-Calmette Guerin in intermediate and high-risk non-muscle invasive bladder cancerShreyas Nellamkuziyil Michael, Arun Makkar, Supreeth Nagaraju, et al.
Pageof 1